Drugs / Orotic acid

Trials 2

20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 21 trial
Phase 2 NCT01620268 Jul 2012 → Jun 2018 — Changzheng-Cinkate Terminated No outcome recorded Stop: Enrollment
Phase not applicable1 trial
— NCT00227058 Jan → Nov 2005 seasonal allergic rhinitis University of Mississippi Medical Center Completed No outcome recorded

Evidence & citations 9 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as Orotic acid ClinicalTrials.gov intervention name — accepted as the source's own label NCT00227058 ↗
1

NCT01620268 ↗

Known as Acide orotique ChEMBL registry synonym — accepted as the source's own label CHEMBL1235017 ↗
Known as Acido orotico ChEMBL registry synonym — accepted as the source's own label CHEMBL1235017 ↗
Known as Animal galactose factor ChEMBL registry synonym — accepted as the source's own label CHEMBL1235017 ↗
Known as NSC-9791 ChEMBL registry synonym — accepted as the source's own label CHEMBL1235017 ↗
Known as Oropur ChEMBL registry synonym — accepted as the source's own label CHEMBL1235017 ↗
Known as Orotyl ChEMBL registry synonym — accepted as the source's own label CHEMBL1235017 ↗
Known as Whey factor ChEMBL registry synonym — accepted as the source's own label CHEMBL1235017 ↗
Modality Small molecule — CHEMBL1235017 ↗